Login / Signup

Efficacy and Safety of Medication for Attention-Deficit Hyperactivity Disorder in Children and Adolescents with Common Comorbidities: A Systematic Review.

Noa TsujiiMasahide UsamiNoriyuki NayaToshinaga TsujiHirokazu MishimaJunko HorieMasakazu FujiwaraJunzo Iida
Published in: Neurology and therapy (2021)
Limited information is available from placebo-controlled RCTs on the efficacy (by ADHD-RS-IV) or safety of medication in children with ADHD and psychiatric comorbidities. Further studies are required to support evidence-based drug selection for these populations.
Keyphrases